Skip to main content
CMEducation Resources ScrollCall
  • menu
  • menu
  • person
  • Search
  • Specialty
  • Cardiology chevron_right

  • Specialty Program
  • Fabry Disease chevron_right
  • Hypothyroidism chevron_right
  • Pain Management chevron_right
  • Glycemic Regulation chevron_right
  • PCSK9s in Interventional Cardiology chevron_right
  • PCSK9s in Medical Preventative chevron_right
  • PCSK9s in Lipid Medicine & Atherosclerosis Prevention chevron_right
  • PCSK9s in Diabetes Management chevron_right
  • PCSK9s: A Multi-Specialty Perspective chevron_right
  • Specialty
  • Diabetes chevron_right

  • Specialty Program
  • Fabry Disease chevron_right
  • Hypothyroidism chevron_right
  • Glycemic Regulation chevron_right
  • PCSK9s in Diabetes Management chevron_right
  • Specialty Program
  • Hypothyroidism chevron_right
  • Specialty Program
  • Parkinson's Diseasechevron_right
  • Specialty
  • Cancer chevron_right

  • Specialty Program
  • Extracorporeal Photopheresis (ECP) chevron_right
  • Pain Management chevron_right
  • Specialty
  • Primary Care chevron_right

  • Specialty Program
  • Atopic Dermatitischevron_right
  • Fabry Disease chevron_right
  • Hypothyroidism chevron_right
  • Pain Management chevron_right
  • Parkinson's Diseasechevron_right
  • Glycemic Regulation chevron_right
  • Specialty
  • Dermatology chevron_right

  • Specialty Program
  • Atopic Dermatitischevron_right
  • Fabry Disease chevron_right
  • Extracorporeal Photopheresis (ECP) chevron_right
  • Specialty
  • Biologicschevron_right

  • Specialty Program
  • Atopic Dermatitischevron_right
  • Fabry Disease chevron_right
  • Biosimilars for RA chevron_right
  • PCSK9s in Interventional Cardiology chevron_right
  • PCSK9s in Medical Preventative chevron_right
  • PCSK9s in Lipid Medicine & Atherosclerosis Prevention chevron_right
  • PCSK9s in Diabetes Management chevron_right
  • PCSK9s: A Multi-Specialty Perspective chevron_right
  • Fabry Disease chevron_right
  • Specialty
  • MAC Lung Disease chevron_right

  • Specialty Program
  • MAC Lung Disease chevron_right
    • close
    CMEducation Resources iQ&A
    • person
    • Program Home
    • Access All Programs
    • Specialtieschevron_right
      • chevron_leftTopics
      • Biologics
      • Cancer
      • Cardiology
      • Dermatology
      • Diabetes
      • Hypothyroidism
      • MAC Lung Disease
      • Neurology
      • Primary Care
    • Submit A Question
    close

    Paula Luna, MD

    Paula Luna, MD

    Director of the Fellowship on Psoriasis
    and Other Inflammatory Disease
    Hospital Aleman
    Buenos Aires, Argentina


    Related Videos

    What is the pathophysiology of the angiokeratomas and telangiectasias seen in FD, what is the typical distribution of these lesions—in male versus female patients—and with what other conditions might these be confused? Video

    What is the pathophysiology of the angiokeratomas and telangiectasias seen in FD, what is the typical distribution of these lesions—in male versus female patients—and with what other conditions might these be confused?

    What are the characteristic angiokeratoma skin lesions and dermatologic hallmarks associated with Fabry Disease (FD)? At what age do they present? In what distribution? With what other conditions might they be confused in the differential diagnosis? Video

    What are the characteristic angiokeratoma skin lesions and dermatologic hallmarks associated with Fabry Disease (FD)? At what age do they present? In what distribution? With what other conditions might they be confused in the differential diagnosis?

    At what point in the natural history of FD do the dermatologic manifestations of FD appear? Do they tend to appear prior or after other collateral manifestations - GI symptoms or acroparesthesias? Video

    At what point in the natural history of FD do the dermatologic manifestations of FD appear? Do they tend to appear prior or after other collateral manifestations - GI symptoms or acroparesthesias?

    What percentage of patients with FD actually have dermatologic manifestations? Video

    What percentage of patients with FD actually have dermatologic manifestations?

    What are the ophthalmologic findings of FD and how are they temporally related to the dermatologic manifestations of FD? Video

    What are the ophthalmologic findings of FD and how are they temporally related to the dermatologic manifestations of FD?

    What is the natural history of FD dermatologic lesions over time? Do the angiokeratomas and telangiectasias evolve, change distribution, or regress over time? What is the differential diagnosis? What does a biopsy show? Video

    What is the natural history of FD dermatologic lesions over time? Do the angiokeratomas and telangiectasias evolve, change distribution, or regress over time? What is the differential diagnosis? What does a biopsy show?

    If FD disease is diagnosed by a dermatologist during childhood or adolescence, what is the therapeutic/management/referral roadmap in this patient population? How do you approach the multi-disciplinary nature of this condition? Video

    If FD disease is diagnosed by a dermatologist during childhood or adolescence, what is the therapeutic/management/referral roadmap in this patient population? How do you approach the multi-disciplinary nature of this condition?

    When you encounter angiokeratomas that you think are characteristic of FD, what is your next step in the diagnostic process? Do you routinely biopsy the lesions? What are the characteristic findings, and do you do genetic testing? Video

    When you encounter angiokeratomas that you think are characteristic of FD, what is your next step in the diagnostic process? Do you routinely biopsy the lesions? What are the characteristic findings, and do you do genetic testing?

    How often are the dermatologic manifestations of FD the portal of entry into the diagnosis of this condition, and what is the role of the dermatologist for ensuring the diagnosis of FD is made as early as possible? Video

    How often are the dermatologic manifestations of FD the portal of entry into the diagnosis of this condition, and what is the role of the dermatologist for ensuring the diagnosis of FD is made as early as possible?

    Disclaimer:
    Copyright © by CMEducation Resources, LLC All rights reserved. Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.
    Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.
    Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.
    Opinions expressed herein are not necessarily those of CMEducation Resources, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

    Clinical Webcasts®

    Powered by BroadcastMedBROADCASTMED